Saxagliptin versus glipizide as add-on therapy to metformin: Assessment of hypoglycemia

Authors

Matthew Mintz, George Washington UniversityFollow
Gianmaria Minervini, AstraZeneca, Wilmington, DE

Document Type

Response or Comment

Publication Date

5-2014

Journal

Current Medical Research and Opinion

Volume

Volume 30, Issue 5

Inclusive Pages

761-770

Keywords

Adamantane--analogs & derivatives; Diabetes Mellitus, Type 2--blood; Diabetes Mellitus, Type 2--drug therapy; Dipeptides--adminsitration & dosage; Glipizide--administration & dosage; Hypoglycemia--blood; Hypoglycemia--prevention & control; Metformin--administration & dosage

Comments

Comment in

Hypoglycemia, its implications in clinical practice, and possible ways to prevent it. [Curr Med Res Opin. 2014]

APA Citation

Mintz, M.L., Minervini, G. (2014). Saxagliptin versus glipizide as add-on therapy to metformin: Assessment of hypoglycemia. Current Medical Research and Opinion, 30(5), 761-770.